| Dr Charles Joshua Stallings, PHARM D | |
|
Psc 3 Unit 2040, Apo, AP 96266 | |
| (315) 784-2185 | |
| Not Available |
| Full Name | Dr Charles Joshua Stallings |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | Psc 3 Unit 2040, Apo, Armed Forces Pacific |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396026571 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 22152 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles Joshua Stallings, PHARM D Psc 3 Unit 2040, 51 Mdss, Apo, AP 96266 Ph: () - | Dr Charles Joshua Stallings, PHARM D Psc 3 Unit 2040, Apo, AP 96266 Ph: (315) 784-2185 |
News Archive
For many years antidepressants, which are believed to work by dampening pain signals, have been the first-line drugs for neuropathic pain. "It is usual to start with an antidepressant like amitriptyline, and if this fails then try an anticonvulsant," says Phil Wiffen, a researcher at Churchill Hospital in Oxford, England. "The results of these meta-analyses suggest this is probably still the best approach to take."
Populus Global Solutions Inc., a New Brunswick, Canada-based company, is pleased to report that the Government of Barbados has launched its new National Health Information System using the Populus technology.
Santarus, Inc. announced today the U.S. commercial launch of UCERIS (budesonide) extended release tablets for the induction of remission in patients with active, mild to moderate ulcerative colitis.
Aggressive blood sugar control does not improve survival in diabetic patients with kidney failure, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology. The results suggest that physicians should individualize blood sugar targets for these patients and not rely on recommendations based on studies in the general population.
Obsessive-compulsive disorder is often diagnosed too late in children and adolescents. In the current issue of Deutsches Ärzteblatt International, Susanne Walitza and her colleagues point out that appropriate early recognition and treatment can positively affect the course of the disease.
› Verified 2 days ago
Dr. Timothy Ray Corbin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Andersen Air Force Base, Unit 14010, Apo, AP 96543 Phone: 671-366-7456 | |
Dr. Shea M Beal, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 121st General Hospital, Unit 15244, Apo, AP 96205 Phone: 011-822-79177984 | |
Nara Shin, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Psc 444, Apo, AP 96297 Phone: 817-301-8910 | |
Mi Sook Bae, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Unit 15245 Bldg 3031, Apo, AP 96279 Phone: 031-573-7207 | |
Julie Won, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Unit 15244, Apo, AP 96205 Phone: 010-737-2068 | |
Mr. Tak Li, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 374 Mdg, Unit 5071, Apo, AP 96328 Phone: 011-834-2225 | |
Richard Paul Wallace, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Psc 80, Box 13059, Apo, AP 96367 Phone: 080-479-77955 |